Global growth opportunities for neurological therapies


Neurological diseases refer to disorders of the brain, nerves, and spinal cord that lead to structural, biochemical, or electrical complications in the body. The main causes of neurological disorders include damage to the brain, spinal cord or nerve; genetic disorders; congenital anomalies; infections; and way of life.

New York, November 11, 2021 (GLOBE NEWSWIRE) – announces the publication of the report “Global Neurological Therapies Growth Opportunities” –

Neurological diseases include a wide range of disorders, such as Alzheimer’s disease, Parkinson’s disease, amyotrophic lateral sclerosis (ALS), multiple sclerosis (MS), epilepsy, autism, neuromuscular disorders , brain tumors and cerebral palsy. Some congenital neurological disorders emerge before birth.

Other diseases are caused by trauma, infections, tumors, neurodegeneration, or structural defects. The pharmaceutical industry devotes considerable sums to the development of new technologies for the treatment of neurodegenerative diseases.

Neurodegenerative diseases are among the most difficult neurological disorders to cure and which have devastating consequences. Neurodegenerative diseases are a diverse group of disorders that involve a progressive degeneration of the structure and function of the central or peripheral nervous system. Two of the most common neurodegenerative diseases are Alzheimer’s disease and Parkinson’s disease, which affect millions of people around the world. The complex nature of neurodegenerative disorders, minimal understanding of disease mechanisms, lack of disease modifying treatment solutions, and multiple disease pathologies are some of the main challenges addressed in this report. Additionally, manufacturing, logistics, and drug delivery across the blood brain barrier are other challenges in the development of potential drugs for neurodegenerative disorders. Academic institutions, public and private organizations and businesses are developing new technologies to cure neurodegenerative diseases. The analyst identified technological advancements in the following established therapies: small molecule, advanced biologics, nucleic acid therapy and cell therapy. This research has identified new approaches under development for delivering drugs across the blood-brain barrier. In addition, the strategic decisions made in the neuroscience industry are highlighted in the report. Patents for technologies under development to treat neurodegenerative disorders are discussed. The competitive landscape and product portfolio analysis of companies focusing specifically on therapeutic interventions for neurodegenerative diseases are assessed. Growth opportunities as well as recommended actions for companies involved in the global neurodegenerative therapy space are discussed in this research study. Key points discussed 1. Main neurodegenerative diseases and challenges in their treatment 2. Emerging therapies for neurodegenerative diseases 3. New drug delivery systems and key advancements 4. Industry landscape and patent filing trends 5. Key growth opportunities for industry players
Read the full report:

On Report link
ReportLinker is an award winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.


CONTACT: Clare: [email protected] US: (339)-368-6001 Intl: +1 339-368-6001

Source link


Leave A Reply